在性结肠炎中使用黄素的临床前证据:元分析和系统审查
Yiyi Feng1, Xingyao Lu2,3, Enjia Guo2
1Department of Traditional Chinese Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Frontiers in pharmacology
|August 14, 2025
概括
在动物模型中,素 (LUT) 通过减少炎症和改善肠道屏障功能来治疗性结肠炎 (UC) 是有前途的. 需要进一步的研究来证实这些治疗效应在人类.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,治疗选择有限.
- 素 (LUT) 是一种天然的黄类化合物,已证明对UC有潜在的治疗益处.
- 在UC中LUT影响的确切药理机制需要进一步阐明.
研究的目的:
- 在性结肠炎 (UC) 的动物模型中进行元分析,评估素 (LUT) 的药理作用.
- 研究LUT在UC中发挥治疗作用的潜在作用机制.
主要方法:
- 在五个主要数据库 (PubMed,Web of Science,Embase,EBSCO,ScienceDirect) 进行了系统的文献搜索,截至2025年3月.
- 在元分析中包含了19项符合条件的研究,涉及327名动物受试者.
- 统计分析是使用标准平均差异进行的,在R软件中具有95%的置信区间.
主要成果:
- 素 (LUT) 显著改善了UC症状,包括降低了疾病活性指数,改善了结肠长度,减轻了体重减轻,并降低了组织学分数.
- 机械分析显示,通过减少促炎性细胞因子,增加抗炎性细胞因子,增强紧结蛋白表达和减轻氧化应激,LUT的有效性.
- LUT对肠道微生物群的α多样性没有显著影响.
结论:
- 素 (LUT) 在性结肠炎 (UC) 的临床前模型中通过抗氧化,抗炎,免疫调节和屏障保护机制显示出显著的治疗潜力.
- 这些发现支持LUT作为UC的潜在治疗剂.
- 需要进一步的临床试验和翻译研究来验证这些研究结果在人类患者中.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
237
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
237
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
420
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
420
Inflammatory Bowel Disease I: Ulcerative Colitis
324
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
324
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
200
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
200
Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189


